Publications by authors named "Brian D Kent"

Claim this Profile
C
Clinical Accuracy and Risk of Harm in Asthma-Related Content on TikTok.
Emma McNally, John Murray, Brian D Kent

Chest· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumab.
David J Jackson, Liam G Heaney, Marc Humbert, Brian D Kent, Anat Shavit

Immunotherapy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does inhaler adherence really matter in severe asthma?
Gráinne d'Ancona, Brian D Kent

Breathe (Sheff)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.
Alexandra M Nanzer, Anne-Catherine Maynard-Paquette, Vardah Alam, Linda Green, Louise Thomson, Brian D Kent

J Allergy Clin Immunol Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease.
Nayia Petousi, Ian D Pavord, Brian Daniel Kent

Thorax· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
David J Jackson, Liam G Heaney, Marc Humbert, Brian D Kent, Anat Shavit

Lancet· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing and managing pleural disease.
Brian D Kent

Breathe (Sheff)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease.
Katherine J Myall, Alex G West, Jennifer L Martinovic, Jodie L Lam, Diana Roque, Brian D Kent

Chest· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing face of the modern respiratory clinician.
Brian D Kent

Breathe (Sheff)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma.
Alexandra M Nanzer, Victoria Taylor, Andrew P Hearn, Joanne E Kavanagh, Tanya Patrick, Brian D Kent

Eur Respir J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial.
Elaine Mac Hale, Garrett Greene, Christopher Mulvey, Matshediso C Mokoka, Job F M van Boven, Brian D Kent

Lancet Respir Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Climate change, the environment and respiratory disease.
Brian D Kent

Breathe (Sheff)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary vascular disease for the general respiratory clinician.
Brian D Kent

Breathe (Sheff)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency medical admissions and COVID-19: impact on 30-day mortality and hospital length of stay.
Richard P Conway, Declan G Byrne, Deirdre M R O'Riordan, Brian D Kent, Barry M J Kennedy

Ir J Med Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What we do and do not know about managing respiratory disease in pregnancy.
Brian D Kent

Breathe (Sheff)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management.
Hitasha Rupani, Brian D Kent

Chest· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious disease in respiratory medicine.
Brian D Kent

Breathe (Sheff)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy in respiratory disease.
Brian D Kent

Breathe (Sheff)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep medicine and coronavirus disease 2019.
Cara M Gill, Laura M Piggott, Brian D Kent

Curr Opin Pulm Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma.
Grainne d'Ancona, Joanne E Kavanagh, Jaideep Dhariwal, Andrew P Hearn, Cris Roxas, Brian D Kent

Allergy· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma.
Joanne E Kavanagh, Andrew P Hearn, Grainne d'Ancona, Jaideep Dhariwal, Cris Roxas, Brian D Kent

Allergy· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy.
Andrew P Hearn, Oliver D Hug, Ziana A Somani, Joanne Kavanagh, Grainne d'Ancona, Brian D Kent

Eur Respir J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.
Jaideep Dhariwal, Andrew P Hearn, Joanne E Kavanagh, Gráinne d'Ancona, Linda Green, Brian D Kent

J Allergy Clin Immunol Pract· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma.
Andrew P Hearn, Joanne Kavanagh, Grainne d'Ancona, Cris Roxas, Linda Green, Brian D Kent

J Allergy Clin Immunol Pract· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Applications of FeNO Measurement and Inhaler Monitoring Technologies in the Management of Difficult Asthma.
Gráinne d'Ancona, Brian D Kent

J Allergy Clin Immunol Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis